Monitoring the therapeutic response of locally advanced breast cancer patients: Sequential in vivo proton MR spectroscopy study

Journal of Magnetic Resonance Imaging

Volumn 24, Issue 2, 2006, Pages 325-332

  Kumar, Mahesh ^a   Jagannathan, N R ^a   Seenu, V ^a   Dwivedi, S N ^a   Julka, P K ^a   Rath, G K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Breast cancer; In vivo proton MRS; Neoadjuvant chemotherapy; Therapeutic response; Water to fat (W F) value

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PROTON;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IN VIVO STUDY; INTRADUCTAL CARCINOMA; MENSTRUAL CYCLE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEQUENTIAL ANALYSIS; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; TUMOR VOLUME; WATER TO FAT VALUE;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MONITORING, PHYSIOLOGIC; NEOADJUVANT THERAPY; PROTONS; TREATMENT OUTCOME;

EID: 33746871772     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20646     Document Type: Article

References (45)

1. Buzdar AU, Hortobagyi GN, Smith TL, et al. Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs. Cancer 1988;62:2098-2104.
2. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62:2507-2516.
3. Lopez MJ, Andriole DP, Kraybill WG, Khojasteh A. Multimodal therapy in locally advanced breast carcinoma. Am J Surg 1990;160:669-674.
4. Hortobagyi GN, Buzdar AU. Locally advanced breast cancer: a review including the MD Anderson experience. In: Ragaz J, Ariel IM, editors. High risk breast cancer: therapy. Berlin, Germany: Springer-Verlag: 1991. p 382-415.
5. Booser DJ, Hortobagyi GN. Treatment of locally advanced breast cancer. Semin Oncol 1992;19:278-285.
6. Buzdar AU, Singletary SE, Booser DJ, Frye DK, Wasaff B, Hortobagyi GN. Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience. Surg Oncol Clin N Am 1995;4:715-734.
7. Valero V, Buzdar AU, Hortobagyi GN. Locally advanced breast cancer. Oncologist 1996;1:8-17.
8. Aisner J, Morris D, Elias EG, Wiemik PH. Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer. Arch Surg 1982;117:882-887.
9. Bonadonna G, Valagussa P, Brambilla C. et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan. Cancer Institute. J Clin Oncol 1998;16:93-100.
10. Calais G, Berger C, Descamps P. et al. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 1994;74:1283-1288.
11. Huber S, Wagner M, Zuna I, Medl M, Czembirek H, Delorme S. Locally Advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy. Anticancer Res 2000;20:553-558.
12. Cocconi G, Di Blasio B, Alberti G, Bisagni G, Botti E, Peracchia G. Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 1984;4:309-313.
13. Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 1988;169:49-54.
14. Giard RW, Hermans J. The value of aspiration cytologic examination of the breast. Cancer 1992;69:2104-2110.
15. Hiller G, Harney M, Legg S, Hart SA. Fine-needle aspiration cytology in breast disease management: a four year experience. Aust NZ J Surg 1987;57:239-242.
16. Davis PL, McCarty Jr KS. Technologic consideration for breast tumor size assessment. Magn Reson Imaging Clin N Am 1994;2:623-631.
17. Kurtz B, Achten C, Audretsch W, Rezai M, Urban P, Zocholl G. MR mammography assessment of tumor response after neoadjuvant radiochemotherapy of locally advanced breast carcinoma [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1996;164:469-474.
18. Rieber A, Zeitler H, Rosenthal H. et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 1997;70:452-458.
19. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping of monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 1994;2:633-658.
20. Abraham DC, Jones RC, Jones SE, et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996;78:91-100.
21. Trecate G, Ceglia E, Stabile F, et al. Locally advanced breast cancer treated with primary chemotherapy: comparison between magnetic resonance imaging and pathologic evaluation of residual disease. Tumori 1999;85:220-228.
22. Gilles R, Guinebretiere JM, Toussaint C, et al. Locally advanced breast cancer: contrast enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633-638.
23. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001;84:1016-1022.
24. 1H MR spectroscopy of human breast cancer. In: Jagannathan NR, editor. Recent advances in MR imaging and spectroscopy. New Delhi: Jaypee; 2005. p 312-344.
25. Bolan PJ, Henry PG, Baker EH, Meisamy S, Garwood M. Measurement and correction of respiration-induced BO variations in breast 1H MRS at 4 Tesla. Magn Reson Med 2004;52:1239-1245.
26. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209:269-275.
27. 1H MR spectroscopy. J Magn Reson Imaging 1999;10:159-164.
28. Lurie SN, Doraiswamy PM, Husain MM, et al. In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab 1990;71:505-508.
29. Jagannathan NR, Seenu V. Kumar M. Potential of in vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent. Radiology 2002;223:281-282.
30. Jagannathan NR, Singh M, Govlndaraju V, et al. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed 1998;11:414-422.
31. Jagannathan NR, Kumar M, Raghunathan P, Coshic O, Julka PK, Rath GK. Assessment of therapeutic response of human breast carcinoma using in-vivo volume localized proton magnetic reso-nance spectroscopy. Curr Sci 1999;76:777-782.
32. Delille JP, Slanetz PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 2003;228:63-69.
33. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002;15:693-704.
34. Mathur-De Vre R. Biomedical implications of the relaxation behavior of water related to NMR imaging. Br J Radiol 1984;57:955-976.
35. 31P MR spectroscopy at 1.5T. Radiology 1988;169:615-620.
36. Gilligam P, Flangan FL, Redmond OM, et al. Proton magnetic resonance spectroscopy in MR mammographic evaluation of breast cancer. In: Proceedings of the 5th Annual Meeting of ISMRM, Vancouver, Canada, 1997. p 1378.
37. 1H spin-lattice relaxation studies of tissue response to radiotherapy in mice. Phys Med Biol 1983;28:331-340.
38. Thomas MA, Binesh N, Yue K, DeBruhl N. Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer. J Magn Reson Imaging 2001;14:181-186.
39. 1H MRS in vivo. Magn Reson Med 1989;10:210-226.
40. Weis J, Hemmingsson A. Spectroscopy of large volumes: spectroscopic imaging of total body fat. Magn Reson Imaging 2001;19:1239-1243.
41. Kamba M, Kimura K, Koda M, Ogawa T. Proton magnetic resonance spectroscopy for assessment of human body composition. Am J Clin Nutr 2001;73:172-176.
42. Barac-Nieto M, Gupta RK. Use of proton MR spectroscopy and MR imaging to assess obesity. J Magn Reson Imaging 1996;6:235-238.
43. Chai JW, Lin YC, Chen JH, et al. In vivo magnetic resonance (MR) study of fatty liver: importance of intracellular ultrastructural alteration for MR tissue parameters change. J Magn Reson Imaging 2001;14:35-41.
44. Chenevert TL, Meyer CR, Moffat BA, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 2002;1:336-343.
45. Partridge SC, McKinnon GC, Henry RG, Hylton NM. Menstrual cycle variation of apparent diffusion coefficient measured in the normal breast using MRI. J Magn Reson Imaging 2001;14:433-438.